Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration

Trusley, Craig; Ben, Michel; Kupiec, Thomas C; Trissel, Lawrence A

Abstract

Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration

Author(s): Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A

Issue: Mar/Apr 2008 - Compounding Around the World

View All Articles in Issue

Page(s): 156-160

Download in electronic PDF format for $75

Abstract

Palonosetron hydrochloride is a longer-acting selective 5-HT3 receptor antagonist that has been approved for the prevention of chemotherapy-induced nausea and vomiting and is being evaluated for the prevention of postoperative nausea and vomiting. The objective of this study was to evaluate the physical and chemical stability of palonosetron hydrochloride 50 mcg/mL when mixed with any of the neuromuscular blocking drugs cisatracurium besylate 0.5 mg/mL, rocuronium bromide 1 mg/mL, succinylcholine chloride 2 mg/mL, and vecuronium bromide 1 mg/mL during simulated Y-site administration. Triplicate samples of palonosetron hydrochloride with each of the neuromuscular blocking drugs were tested. Samples were stored and evaluated for up to 4 hours at room temperature. Physical stability was assessed by turbidimetric and particulate measurements and visual inspection. Chemical stability was assessed by high-performance liquid chromatography. All of the admixtures were clear and colorless when viewed in normal fluores

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2008 Pg. 156-160	Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Author(s): Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2008 Pg. 170-173	Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Author(s): Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
Jan/Feb 2009 Pg. 78-80	Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration Author(s): Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel
Nov/Dec 2007 Pg. 520-524	Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Jul/Aug 2008 Pg. 368-371	Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Sep/Oct 2008 Pg. 460-462	Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration Author(s): Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
Jan/Feb 2017 Pg. 76-82	Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Author(s): Wu George, Yeung Stanley, Chen Frank
May/Jun 2005 Pg. 238-241	Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A
May/Jun 2005 Pg. 235-237	Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A
Jul/Aug 2002 Pg. 311-315	Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs Author(s): Trissel Lawrence A, Saenz Christopher
Jan/Feb 2018 Pg. 76-85	Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank
Jan/Feb 2018 Pg. 86-94	Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
Sep/Oct 2013 Pg. 436-438	Compatibility of Amiodarone Hydrochloride with Vasopressin During Simulated Y-site Administration Author(s): Ramaley Corrine C, Li Feng, Du Chengan
Jan/Feb 2001 Pg. 69-73	Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs Author(s): Trissel Lawrence A, Williams Kimberly Y, Baker Ma
Jan/Feb 2007 Pg. 82-85	Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration Author(s): Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Jul/Aug 1998 Pg. 318-321	Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration Author(s): Inagaki Kazuhiro, Kambara Motoya, Mizuno Munemichi, Gill Mark A, Nishida Mikio
May/Jun 2008 Pg. 276-278	Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Author(s): Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A
Jul/Aug 2005 Pg. 320-322	Physical and Chemical Stability of Palonosetron Hydrochloride with Fluorouracil and with Gemcitabine Hydrochloride during Simulated Y-site Administration Author(s): Trissel Lawrence A, Zhang Yanping
May/Jun 2006 Pg. 234-236	Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A, Zhang Yanping
May/Jun 2016 Pg. 236-238	Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration Author(s): Mody Vicky, Shah Samit, Patel Jaymin, Thomas Michael C